 | • レポートコード：QYR2104Z5226 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、短腸症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（GLP-2、成長ホルモン、グルタミン、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・短腸症候群の市場動向 ・企業の競争状況、市場シェア ・短腸症候群の種類別市場規模（GLP-2、成長ホルモン、グルタミン、その他） ・短腸症候群の用途別市場規模（病院、クリニック） ・短腸症候群の北米市場規模2016-2027（アメリカ、カナダ） ・短腸症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・短腸症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・短腸症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・短腸症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、Merck、Emmaus Life Sciences、Nutrinia、GlyPharma Therapeutics、OxThera、Ardelyx、Sancilio & Company、Naia Pharmaceuticals、Zealand Pharma） ・結論 |
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
Market Analysis and Insights: Global Short Bowel Syndrome Market
The global Short Bowel Syndrome market size is projected to reach US$ 1362.1 million by 2026, from US$ 444.2 million in 2019, at a CAGR of 17.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Short Bowel Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Short Bowel Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Short Bowel Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Short Bowel Syndrome market.
Global Short Bowel Syndrome Scope and Market Size
Short Bowel Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
GLP-2
Growth Hormone
Glutamine
Others
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Short Bowel Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome Market Perspective (2016-2027)
2.2 Short Bowel Syndrome Growth Trends by Regions
2.2.1 Short Bowel Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Short Bowel Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Short Bowel Syndrome Industry Dynamic
2.3.1 Short Bowel Syndrome Market Trends
2.3.2 Short Bowel Syndrome Market Drivers
2.3.3 Short Bowel Syndrome Market Challenges
2.3.4 Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Short Bowel Syndrome Players by Revenue (2016-2021)
3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome Revenue
3.4 Global Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Revenue in 2020
3.5 Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome Breakdown Data by Type
4.1 Global Short Bowel Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Short Bowel Syndrome Forecasted Market Size by Type (2022-2027)
5 Short Bowel Syndrome Breakdown Data by Application
5.1 Global Short Bowel Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Short Bowel Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Short Bowel Syndrome Market Size (2016-2027)
6.2 North America Short Bowel Syndrome Market Size by Type
6.2.1 North America Short Bowel Syndrome Market Size by Type (2016-2021)
6.2.2 North America Short Bowel Syndrome Market Size by Type (2022-2027)
6.2.3 North America Short Bowel Syndrome Market Size by Type (2016-2027)
6.3 North America Short Bowel Syndrome Market Size by Application
6.3.1 North America Short Bowel Syndrome Market Size by Application (2016-2021)
6.3.2 North America Short Bowel Syndrome Market Size by Application (2022-2027)
6.3.3 North America Short Bowel Syndrome Market Size by Application (2016-2027)
6.4 North America Short Bowel Syndrome Market Size by Country
6.4.1 North America Short Bowel Syndrome Market Size by Country (2016-2021)
6.4.2 North America Short Bowel Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Market Size (2016-2027)
7.2 Europe Short Bowel Syndrome Market Size by Type
7.2.1 Europe Short Bowel Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Short Bowel Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Short Bowel Syndrome Market Size by Type (2016-2027)
7.3 Europe Short Bowel Syndrome Market Size by Application
7.3.1 Europe Short Bowel Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Short Bowel Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Short Bowel Syndrome Market Size by Application (2016-2027)
7.4 Europe Short Bowel Syndrome Market Size by Country
7.4.1 Europe Short Bowel Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Short Bowel Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Short Bowel Syndrome Market Size by Type
8.2.1 Asia-Pacific Short Bowel Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Short Bowel Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Short Bowel Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Short Bowel Syndrome Market Size by Application
8.3.1 Asia-Pacific Short Bowel Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Short Bowel Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Short Bowel Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Short Bowel Syndrome Market Size by Region
8.4.1 Asia-Pacific Short Bowel Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Short Bowel Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Short Bowel Syndrome Market Size (2016-2027)
9.2 Latin America Short Bowel Syndrome Market Size by Type
9.2.1 Latin America Short Bowel Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Short Bowel Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Short Bowel Syndrome Market Size by Type (2016-2027)
9.3 Latin America Short Bowel Syndrome Market Size by Application
9.3.1 Latin America Short Bowel Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Short Bowel Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Short Bowel Syndrome Market Size by Application (2016-2027)
9.4 Latin America Short Bowel Syndrome Market Size by Country
9.4.1 Latin America Short Bowel Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Short Bowel Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Short Bowel Syndrome Market Size by Type
10.2.1 Middle East & Africa Short Bowel Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Short Bowel Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Short Bowel Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Short Bowel Syndrome Market Size by Application
10.3.1 Middle East & Africa Short Bowel Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Short Bowel Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Short Bowel Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Short Bowel Syndrome Market Size by Country
10.4.1 Middle East & Africa Short Bowel Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Short Bowel Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Short Bowel Syndrome Introduction
11.1.4 Takeda Revenue in Short Bowel Syndrome Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Short Bowel Syndrome Introduction
11.2.4 Merck Revenue in Short Bowel Syndrome Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Emmaus Life Sciences
11.3.1 Emmaus Life Sciences Company Details
11.3.2 Emmaus Life Sciences Business Overview
11.3.3 Emmaus Life Sciences Short Bowel Syndrome Introduction
11.3.4 Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2016-2021)
11.3.5 Emmaus Life Sciences Recent Development
11.4 Nutrinia
11.4.1 Nutrinia Company Details
11.4.2 Nutrinia Business Overview
11.4.3 Nutrinia Short Bowel Syndrome Introduction
11.4.4 Nutrinia Revenue in Short Bowel Syndrome Business (2016-2021)
11.4.5 Nutrinia Recent Development
11.5 GlyPharma Therapeutics
11.5.1 GlyPharma Therapeutics Company Details
11.5.2 GlyPharma Therapeutics Business Overview
11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Introduction
11.5.4 GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2016-2021)
11.5.5 GlyPharma Therapeutics Recent Development
11.6 OxThera
11.6.1 OxThera Company Details
11.6.2 OxThera Business Overview
11.6.3 OxThera Short Bowel Syndrome Introduction
11.6.4 OxThera Revenue in Short Bowel Syndrome Business (2016-2021)
11.6.5 OxThera Recent Development
11.7 Ardelyx
11.7.1 Ardelyx Company Details
11.7.2 Ardelyx Business Overview
11.7.3 Ardelyx Short Bowel Syndrome Introduction
11.7.4 Ardelyx Revenue in Short Bowel Syndrome Business (2016-2021)
11.7.5 Ardelyx Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Short Bowel Syndrome Business (2016-2021)
11.8.5 Sancilio & Company Recent Development
11.9 Naia Pharmaceuticals
11.9.1 Naia Pharmaceuticals Company Details
11.9.2 Naia Pharmaceuticals Business Overview
11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Introduction
11.9.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2016-2021)
11.9.5 Naia Pharmaceuticals Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Short Bowel Syndrome Business (2016-2021)
11.10.5 Zealand Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Others
Table 6. Global Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Short Bowel Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Short Bowel Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Short Bowel Syndrome Market Share by Regions (2016-2021)
Table 10. Global Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Short Bowel Syndrome Market Share by Regions (2022-2027)
Table 12. Short Bowel Syndrome Market Trends
Table 13. Short Bowel Syndrome Market Drivers
Table 14. Short Bowel Syndrome Market Challenges
Table 15. Short Bowel Syndrome Market Restraints
Table 16. Global Short Bowel Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Short Bowel Syndrome Market Share by Players (2016-2021)
Table 18. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome as of 2020)
Table 19. Ranking of Global Top Short Bowel Syndrome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Short Bowel Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Table 27. Global Short Bowel Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Short Bowel Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Short Bowel Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Short Bowel Syndrome Revenue Market Share by Application (2016-2021)
Table 31. Global Short Bowel Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Short Bowel Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Short Bowel Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Short Bowel Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 63. Takeda Company Details
Table 64. Takeda Business Overview
Table 65. Takeda Short Bowel Syndrome Product
Table 66. Takeda Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 67. Takeda Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Short Bowel Syndrome Product
Table 71. Merck Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Emmaus Life Sciences Company Details
Table 74. Emmaus Life Sciences Business Overview
Table 75. Emmaus Life Sciences Short Bowel Syndrome Product
Table 76. Emmaus Life Sciences Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 77. Emmaus Life Sciences Recent Development
Table 78. Nutrinia Company Details
Table 79. Nutrinia Business Overview
Table 80. Nutrinia Short Bowel Syndrome Product
Table 81. Nutrinia Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 82. Nutrinia Recent Development
Table 83. GlyPharma Therapeutics Company Details
Table 84. GlyPharma Therapeutics Business Overview
Table 85. GlyPharma Therapeutics Short Bowel Syndrome Product
Table 86. GlyPharma Therapeutics Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 87. GlyPharma Therapeutics Recent Development
Table 88. OxThera Company Details
Table 89. OxThera Business Overview
Table 90. OxThera Short Bowel Syndrome Product
Table 91. OxThera Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 92. OxThera Recent Development
Table 93. Ardelyx Company Details
Table 94. Ardelyx Business Overview
Table 95. Ardelyx Short Bowel Syndrome Product
Table 96. Ardelyx Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 97. Ardelyx Recent Development
Table 98. Sancilio & Company Company Details
Table 99. Sancilio & Company Business Overview
Table 100. Sancilio & Company Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 101. Sancilio & Company Recent Development
Table 102. Naia Pharmaceuticals Company Details
Table 103. Naia Pharmaceuticals Business Overview
Table 104. Naia Pharmaceuticals Short Bowel Syndrome Product
Table 105. Naia Pharmaceuticals Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 106. Naia Pharmaceuticals Recent Development
Table 107. Zealand Pharma Company Details
Table 108. Zealand Pharma Business Overview
Table 109. Zealand Pharma Short Bowel Syndrome Product
Table 110. Zealand Pharma Revenue in Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 111. Zealand Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome Market Share by Type: 2020 VS 2027
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Others Features
Figure 6. Global Short Bowel Syndrome Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Short Bowel Syndrome Report Years Considered
Figure 10. Global Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Short Bowel Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Short Bowel Syndrome Market Share by Regions: 2020 VS 2027
Figure 13. Global Short Bowel Syndrome Market Share by Regions (2022-2027)
Figure 14. Global Short Bowel Syndrome Market Share by Players in 2020
Figure 15. Global Top Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Short Bowel Syndrome Revenue in 2020
Figure 17. Global Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Figure 18. Global Short Bowel Syndrome Revenue Market Share by Type (2022-2027)
Figure 19. North America Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 21. North America Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 22. North America Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 23. United States Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 27. Europe Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 28. Europe Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 29. Germany Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Short Bowel Syndrome Market Share by Region (2016-2027)
Figure 39. China Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 47. Latin America Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 48. Latin America Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 49. Mexico Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 55. Turkey Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 60. Emmaus Life Sciences Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 61. Nutrinia Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 62. GlyPharma Therapeutics Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 63. OxThera Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 64. Ardelyx Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 65. Sancilio & Company Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 66. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 67. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の短腸症候群（SBS）市場規模・現状・予測（2021年-2027年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…- 世界の過敏性腸症候群治療市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in dec…
- 世界の過敏性腸症候群治療市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in dec…
- 世界の過敏性腸症候群治療市場 2021：企業別、地域別、種類・用途別 The Irritable Bowel Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…